Growth Hormone Releasing Peptide 2 (GHRP2)

[Edit]

Pralmorelin

Growth Hormone Releasing Peptide 2 (GHRP2)
Pralmorelin is an orally active, synthetic growth hormone-releasing peptide from a series of compounds that were developed by Polygen in Germany and Tulane University in the US. Researchers at Tulane University led by Dr Cyril Bowers synthesised a series of small highly active peptides ranging in size from 3-5 amino acids or partial peptides that were suitable for a variety of administration formats. These peptides mimic the actions of ghrelin, a 28 amino acid octanoyl peptide that regulates the release of growth hormone (GH), and may play an important role in bone and muscle growth, food intake and possibly improve recovery from injury. The use of pralmorelin as a diagnostic agent for GH deficiency is based on its ability to markedly increase plasma levels of GH in healthy subjects irrespectively of gender, obesity or age.

Organism species: Pan-species (General)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Complete Antigen of Growth Hormone Releasing Peptide 2 (GHRP2) Antigenic Transformation Customized Service Offer
Antibodies n/a Monoclonal Antibody to Growth Hormone Releasing Peptide 2 (GHRP2) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Growth Hormone Releasing Peptide 2 (GHRP2) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Growth Hormone Releasing Peptide 2 (GHRP2) CLIA Kit Customized Service Offer
n/a ELISA Kit for Growth Hormone Releasing Peptide 2 (GHRP2) ELISA Kit Customized Service Offer